Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer

The management of advanced castration resistant prostate cancer (CRPC) has been rapidly changing and is still evolving. In the last years, there has been an increasing knowledge of prostate cancer biology. New therapeutic agents and approaches have been evaluated demonstrating benefits in survival a...

Descripción completa

Detalles Bibliográficos
Autores principales: Recine, Federica, Sternberg, Cora N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708230/
https://www.ncbi.nlm.nih.gov/pubmed/26816835
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708230/
https://www.ncbi.nlm.nih.gov/pubmed/26816835
http://dx.doi.org/10.3978/j.issn.2223-4683.2015.04.11

Ejemplares similares